Michael Gruber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Michael Gruber has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Birgit Hirschmugl
Department of Obstetrics and Gynaecology Medical University of Graz Graz Austria
3 shared publications - Christian Wadsack
Medical University of Graz
3 shared publications - Martin Gauster
Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Medical University of Graz , Graz
3 shared publications Birgit Hirschmugl
Medizinische Universitat Graz
2 shared publicationsCarolin Schliefsteiner
Medizinische Universitat Graz
2 shared publications- Carolin Schliefsteiner
Medical University of Graz
2 shared publications
Latest Publications
- 28 February 2023
- Published by Springer Nature
- p. 333-348
Research Aspects and In Vitro Models
- 28 February 2023
- Published by Springer Nature
- p. 77-90
Placental Function—Nutrient Transport—Gas Exchange
- 28 February 2023
- Published by Springer Nature
- p. 77-90
Placental Function—Nutrient Transport—Gas Exchange
- Open Access
- 24 June 2021
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 156 (4) , 363-375
Flow-through isolation of human first trimester umbilical cord endothelial cells
Human umbilical vein and artery endothelial cells (HUVEC; HUAEC), placental endothelial cells (fpAEC), and endothelial colony-forming cells (ECFC) from cord blood are a widely used model for researching placental vascular development, fetal and placental endothelial function, and the effect of adverse conditions in pregnancy thereon. However, placental vascular development and angiogenesis start in the first weeks of gestation, and adverse conditions in pregnancy may also affect endothelial function before term, suggesting that endothelial cells from early pregnancy may respond differently. Thus, we established a novel, gentle flow-through method to isolate pure human umbilical endothelial cells from first trimester (FTUEC). FTUEC were characterized and their phenotype was compared to the umbilical endothelium in situ as well as to other fetal endothelial cell models from term of gestation, i.e. HUVEC, fpAEC, ECFC. FTUEC possess a CD34-positive, juvenile endothelial phenotype, and can be expanded and passaged. We regard FTUEC as a valuable tool to study developmental processes as well as the effect of adverse insults in pregnancy in vitro.
- 24 June 2021
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 156 (4) , 363-375
Open AccessFlow-through isolation of human first trimester umbilical cord endothelial cells
Human umbilical vein and artery endothelial cells (HUVEC; HUAEC), placental endothelial cells (fpAEC), and endothelial colony-forming cells (ECFC) from cord blood are a widely used model for researching placental vascular development, fetal and placental endothelial function, and the effect of adverse conditions in pregnancy thereon. However, placental vascular development and angiogenesis start in the first weeks of gestation, and adverse conditions in pregnancy may also affect endothelial function before term, suggesting that endothelial cells from early pregnancy may respond differently. Thus, we established a novel, gentle flow-through method to isolate pure human umbilical endothelial cells from first trimester (FTUEC). FTUEC were characterized and their phenotype was compared to the umbilical endothelium in situ as well as to other fetal endothelial cell models from term of gestation, i.e. HUVEC, fpAEC, ECFC. FTUEC possess a CD34-positive, juvenile endothelial phenotype, and can be expanded and passaged. We regard FTUEC as a valuable tool to study developmental processes as well as the effect of adverse insults in pregnancy in vitro.
- Open Access
- 9 September 2020
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 18 (1) , 1-14
Plasma proteins facilitates placental transfer of polystyrene particles
Background: Nanoparticles, which are exposed to biological fluids are rapidly interacting with proteins and other biomolecules forming a corona. In addition to dimension, charge and material the distinct protein corona influences the interplay of nanoparticles with tissue barriers. In this study we were focused on the impact of in situ formed human plasma protein corona on the transfer of 80 nm polystyrene nanoparticles (PS-particles) across the human placenta. To study materno-to fetal PS transfer we used the human ex vivo placental perfusion approach, which represents an intact and physiological tissue barrier. To analyze the protein corona of PS particles we performed shotgun proteomics of isolated nanoparticles before and after tissue exposure. Results: Human plasma incubated with PS-particles of 80 nm and subsequent formed protein corona enhanced the transfer across the human placenta compared to PS-corona formed by bovine serum albumin and dextran which served as a control. Quantitative and qualitative changes of plasma proteins determined the changes in PS transfer across the barrier. Based on the analysis of the PS-proteome two candidate proteins, namely human albumin and immunoglobulin G were tested if these proteins may account for the enhanced PS-transfer across the placenta. Interestingly, the protein corona formed by human albumin significantly induced the transfer of PS-particles across the tissue compared to the formed IgG-corona. Conclusion: In total we demonstrate the PS corona dynamically and significantly evolves upon crossing the human placenta. Thus, the initial composition of PS particles in the maternal circulation is not predictive for their transfer characteristics and performance once beyond the barrier of the placenta. The precise mechanism of these effects remains to be elucidated but highlights the importance of using well designed biological models when testing nanoparticles for biomedical applications.
- 9 September 2020
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 18 (1) , 1-14
Open AccessPlasma proteins facilitates placental transfer of polystyrene particles
Background: Nanoparticles, which are exposed to biological fluids are rapidly interacting with proteins and other biomolecules forming a corona. In addition to dimension, charge and material the distinct protein corona influences the interplay of nanoparticles with tissue barriers. In this study we were focused on the impact of in situ formed human plasma protein corona on the transfer of 80 nm polystyrene nanoparticles (PS-particles) across the human placenta. To study materno-to fetal PS transfer we used the human ex vivo placental perfusion approach, which represents an intact and physiological tissue barrier. To analyze the protein corona of PS particles we performed shotgun proteomics of isolated nanoparticles before and after tissue exposure. Results: Human plasma incubated with PS-particles of 80 nm and subsequent formed protein corona enhanced the transfer across the human placenta compared to PS-corona formed by bovine serum albumin and dextran which served as a control. Quantitative and qualitative changes of plasma proteins determined the changes in PS transfer across the barrier. Based on the analysis of the PS-proteome two candidate proteins, namely human albumin and immunoglobulin G were tested if these proteins may account for the enhanced PS-transfer across the placenta. Interestingly, the protein corona formed by human albumin significantly induced the transfer of PS-particles across the tissue compared to the formed IgG-corona. Conclusion: In total we demonstrate the PS corona dynamically and significantly evolves upon crossing the human placenta. Thus, the initial composition of PS particles in the maternal circulation is not predictive for their transfer characteristics and performance once beyond the barrier of the placenta. The precise mechanism of these effects remains to be elucidated but highlights the importance of using well designed biological models when testing nanoparticles for biomedical applications.
- 19 April 2018
- Published by Springer Nature
- p. 75-88
Plazentafunktion – Nährstofftransport – Gasaustausch
- 19 April 2018
- Published by Springer Nature
- p. 75-88
Plazentafunktion – Nährstofftransport – Gasaustausch
- 19 April 2018
- Published by Springer Nature
- p. 341-357
Forschungsaspekte und In-vitro-Modelle